• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Mode of neutralization of lactate dehydrogenase-elevating virus by polyclonal and monoclonal antibodies.多克隆抗体和单克隆抗体对乳酸脱氢酶升高病毒的中和模式。
Arch Virol. 1992;123(1-2):89-100. doi: 10.1007/BF01317140.
2
Formalin inactivation of the lactate dehydrogenase-elevating virus reveals a major neutralizing epitope not recognized during natural infection.乳酸脱氢酶升高病毒经福尔马林灭活后揭示出一个在自然感染期间未被识别的主要中和表位。
J Virol. 1988 Sep;62(9):3210-6. doi: 10.1128/JVI.62.9.3210-3216.1988.
3
Complexity of the single linear neutralization epitope of the mouse arterivirus lactate dehydrogenase-elevating virus.小鼠动脉炎病毒乳酸脱氢酶升高病毒单一线性中和表位的复杂性
Virology. 2001 Nov 10;290(1):11-20. doi: 10.1006/viro.2001.1139.
4
Immune response to lactate dehydrogenase-elevating virus: serologically specific rabbit neutralizing antibody to the virus.对乳酸脱氢酶升高病毒的免疫反应:对该病毒具有血清学特异性的兔中和抗体。
Infect Immun. 1982 Sep;37(3):1007-12. doi: 10.1128/iai.37.3.1007-1012.1982.
5
Neutralization and sensitization of lactate dehydrogenase-elevating virus with monoclonal antibodies.用单克隆抗体中和及致敏乳酸脱氢酶升高病毒
J Gen Virol. 1988 Aug;69 ( Pt 8):2097-100. doi: 10.1099/0022-1317-69-8-2097.
6
Difference in neutralization between lactate dehydrogenase-elevating virus isolated from acutely and chronically infected mice.从急性和慢性感染小鼠中分离出的乳酸脱氢酶升高病毒之间的中和差异。
J Gen Virol. 1994 May;75 ( Pt 5):1173-6. doi: 10.1099/0022-1317-75-5-1173.
7
Neuropathogenicity and sensitivity to antibody neutralization of lactate dehydrogenase-elevating virus are determined by polylactosaminoglycan chains on the primary envelope glycoprotein.乳酸脱氢酶升高病毒的神经致病性和对抗体中和的敏感性由主要包膜糖蛋白上的聚乳糖胺聚糖链决定。
Virology. 2000 Jan 5;266(1):88-98. doi: 10.1006/viro.1999.0050.
8
Selective antibody neutralization prevents neuropathogenic lactate dehydrogenase-elevating virus from causing paralytic disease in immunocompetent mice.选择性抗体中和可防止神经致病性乳酸脱氢酶升高病毒在免疫功能正常的小鼠中引起麻痹性疾病。
J Neurovirol. 1999 Apr;5(2):200-8. doi: 10.3109/13550289909022003.
9
Antibody response of mice to lactate dehydrogenase-elevating virus during infection and immunization with inactivated virus.小鼠在感染乳酸脱氢酶升高病毒及用灭活病毒免疫期间对该病毒的抗体反应。
Virus Res. 1986 Sep;5(4):357-75. doi: 10.1016/0168-1702(86)90029-8.
10
The neutralization epitope of lactate dehydrogenase-elevating virus is located on the short ectodomain of the primary envelope glycoprotein.乳酸脱氢酶升高病毒的中和表位位于主要包膜糖蛋白的短胞外域上。
Virology. 1998 Mar 15;242(2):239-45. doi: 10.1006/viro.1997.9014.

引用本文的文献

1
Increased efficacy of the immunoglobulin G2a subclass in antibody-mediated protection against lactate dehydrogenase-elevating virus-induced polioencephalomyelitis revealed with switch mutants.利用转换突变体揭示免疫球蛋白G2a亚类在抗体介导的抗乳酸脱氢酶升高病毒诱导的脑脊髓灰质炎保护中的功效增强。
J Virol. 2002 Jan;76(1):432-5. doi: 10.1128/jvi.76.1.432-435.2002.
2
Lactate dehydrogenase-elevating virus: an ideal persistent virus?乳酸脱氢酶升高病毒:一种理想的持续性病毒?
Springer Semin Immunopathol. 1995;17(2-3):167-86. doi: 10.1007/BF00196164.
3
Disulfide bonds between two envelope proteins of lactate dehydrogenase-elevating virus are essential for viral infectivity.乳酸脱氢酶升高病毒两种包膜蛋白之间的二硫键对病毒感染性至关重要。
J Virol. 1995 Jan;69(1):613-7. doi: 10.1128/JVI.69.1.613-617.1995.
4
Lactate dehydrogenase-elevating virus, equine arteritis virus, and simian hemorrhagic fever virus: a new group of positive-strand RNA viruses.乳酸脱氢酶升高病毒、马动脉炎病毒和猴出血热病毒:一组新的正链RNA病毒。
Adv Virus Res. 1992;41:99-192. doi: 10.1016/s0065-3527(08)60036-6.

本文引用的文献

1
Semliki Forest virus multiplication in clones of Aedes albopictus cells.辛德毕斯病毒在白纹伊蚊细胞克隆中的增殖。
J Virol. 1981 Feb;37(2):589-600. doi: 10.1128/JVI.37.2.589-600.1981.
2
Immune response to lactate dehydrogenase-elevating virus: serologically specific rabbit neutralizing antibody to the virus.对乳酸脱氢酶升高病毒的免疫反应:对该病毒具有血清学特异性的兔中和抗体。
Infect Immun. 1982 Sep;37(3):1007-12. doi: 10.1128/iai.37.3.1007-1012.1982.
3
Replication of lactate dehydrogenase-elevating virus in macrophages. 1. Evidence for cytocidal replication.乳酸脱氢酶升高病毒在巨噬细胞中的复制。1. 细胞杀伤性复制的证据。
J Gen Virol. 1982 Apr;59(Pt 2):245-62. doi: 10.1099/0022-1317-59-2-245.
4
Virus-induced immune complex disease: specific anti-viral antibody and C1q binding material in the circulation during persistent lymphocytic choriomeningitis virus infection.病毒诱导的免疫复合物疾病:持续性淋巴细胞性脉络丛脑膜炎病毒感染期间循环中的特异性抗病毒抗体和C1q结合物质
J Immunol. 1980 Feb;124(2):831-8.
5
Replication of lactate dehydrogenase-elevating virus in macrophages. 2. Mechanism of persistent infection in mice and cell culture.乳酸脱氢酶升高病毒在巨噬细胞中的复制。2. 小鼠和细胞培养中持续感染的机制。
J Gen Virol. 1982 Apr;59(Pt 2):263-72. doi: 10.1099/0022-1317-59-2-263.
6
The structure of togaviruses.披膜病毒的结构。
Prog Med Virol. 1973;16:109-56.
7
Lactate dehydrogenase-elevating virus.乳酸脱氢酶升高病毒
J Gen Virol. 1985 Nov;66 ( Pt 11):2297-312. doi: 10.1099/0022-1317-66-11-2297.
8
Cell surface receptors for lactate dehydrogenase-elevating virus on subpopulation of macrophages.巨噬细胞亚群上乳酸脱氢酶升高病毒的细胞表面受体
Virus Res. 1985 Apr;2(3):211-29. doi: 10.1016/0168-1702(85)90010-3.
9
Antibody and complement in viral infections.病毒感染中的抗体与补体。
Br Med Bull. 1985 Jan;41(1):3-6. doi: 10.1093/oxfordjournals.bmb.a072020.
10
Ia antigens and Fc receptors of mouse peritoneal macrophages as determinants of susceptibility to lactic dehydrogenase virus.小鼠腹腔巨噬细胞的Ia抗原和Fc受体作为对乳酸脱氢酶病毒易感性的决定因素。
J Gen Virol. 1985 Jul;66 ( Pt 7):1469-77. doi: 10.1099/0022-1317-66-7-1469.

多克隆抗体和单克隆抗体对乳酸脱氢酶升高病毒的中和模式。

Mode of neutralization of lactate dehydrogenase-elevating virus by polyclonal and monoclonal antibodies.

作者信息

Plagemann P G, Harty J T, Even C

机构信息

Department of Microbiology, University of Minnesota Medical School, Minneapolis.

出版信息

Arch Virol. 1992;123(1-2):89-100. doi: 10.1007/BF01317140.

DOI:10.1007/BF01317140
PMID:1372497
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7087216/
Abstract

Neutralization of the infectivity of [3H]uridine-labeled lactate dehydrogenase-elevating virus (LDV) by polyclonal mouse or rabbit antibodies to the envelope glycoprotein of LDV, VP-3, or by neutralizing monoclonal antibodies (mAb) that recognize a different epitope on VP-3 than the polyclonal antibodies correlated with an increase in the sedimentation rate of LDV from 230 S to greater than or equal to 270 S. Incubation of LDV with normal mouse plasma or non-neutralizing mAbs to LDV VP-3 had no effect on its sedimentation rate. Similarly, incubation of a neutralization escape variant of LDV with the mAb used in its selection had no effect on its sedimentation rate, whereas neutralization of this variant by polyclonal mouse or rabbit anti-VP3 antibodies increased the sedimentation rate. Neutralization of LDV infectivity was only observed at high antibody/virion ratios and often was followed by loss of the viral RNA. The results suggest that neutralization of LDV infectivity results from binding of multiple antibody molecules that recognize specific epitopes on the viral envelope glycoprotein and ultimately leads to disintegration of the virions.

摘要

用针对乳酸脱氢酶升高病毒(LDV)包膜糖蛋白VP - 3的多克隆小鼠或兔抗体,或用识别VP - 3上与多克隆抗体不同表位的中和单克隆抗体(mAb)中和[3H]尿苷标记的LDV的感染性,与LDV沉降速率从230 S增加到大于或等于270 S相关。将LDV与正常小鼠血浆或针对LDV VP - 3的非中和mAb孵育对其沉降速率没有影响。同样,将LDV的中和逃逸变体与用于筛选它的mAb孵育对其沉降速率没有影响,而用多克隆小鼠或兔抗VP3抗体中和该变体则增加了沉降速率。仅在高抗体/病毒粒子比率下观察到LDV感染性的中和,并且通常随后病毒RNA丢失。结果表明,LDV感染性的中和是由于识别病毒包膜糖蛋白上特定表位的多个抗体分子的结合,最终导致病毒粒子解体。